Synthesis of 1α, 25-dihydroxyvitamin D3-3β-bromoacetate (1, 25 (OH) 2D3-3-BE), a potential anti-cancer agent is presented. We also report that mechanism of action of 1, 25 (OH) 2D3-3-BE may involve reduction of its catabolism, as evidenced by the reduced and ...